Keyphrases
High Titer
100%
Cheek
100%
Convalescent
100%
Recipient Outcomes
100%
Convalescent Plasma
100%
Donor Selection
100%
Cutaneous Metastasis
100%
Renal Cell Carcinoma
100%
Metastasis
100%
Anti-SARS-CoV-2
100%
Lateral Flow Assay
62%
Titer
50%
Gradient Boosting Regressor
50%
Disease Process
40%
Scalp
40%
Convalescent Plasma Therapy
37%
New York
25%
Receptor-binding Domain
25%
Blood Center
25%
Low Titer
25%
Yield Prediction Model
25%
Malignancy
20%
Head-and-neck Region
20%
Palliative Care
20%
Primary Tumor
20%
Chief Complaint
20%
Clinical Course
20%
Blue Color
20%
Growth Process
20%
Head-and-neck
20%
Tumor Control
20%
Patient History
20%
Cutaneous Presentation
20%
Advanced Disease
20%
Clear Cell
20%
Nephrectomy
20%
Facial Lesion
20%
Rapid Growth
20%
Punch Biopsy
20%
Older Men
20%
Metastatic Renal Cell Carcinoma (mRCC)
20%
Primary Resection
20%
Cell Subtypes
20%
Potential Donor
12%
Severely Ill Patients
12%
Severe Adverse Events
12%
SARS-CoV-2 S1
12%
SARS-CoV-2 Pandemic
12%
Non-associated
12%
Convalescent Patients
12%
Medicine and Dentistry
Cheek
100%
Clear Cell Renal Cell Carcinoma
100%
Metastatic Carcinoma
100%
Skin Metastasis
100%
Neck
60%
Scalp
40%
Disease Process
40%
Punch Biopsy
20%
Nephrectomy
20%
Cancer
20%
Surgery
20%
Disease Course
20%
Primary Tumor
20%
Clear Cell
20%
Symptomatic Treatment
20%
Kidney Metastasis
20%
Immunology and Microbiology
Titer
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Donor Selection
100%
CD34
100%
Blood Plasma
100%
Lateral Flow Assay
41%
Cell Count
33%
Apheresis
33%
Receptor Binding
16%
Hematopoietic Stem Cell Transplantation
11%
Hematopoietic Cell
11%
Filgrastim
11%
Engraftment
11%
Immunoglobulin G
8%
COVID-19
8%
ELISA
8%
Immunoglobulin M
8%
